ANDA201991 for Metformin Hydrochloride Approved by FDA
The FDA has approved the ANDA201991 application for Metformin Hydrochloride submitted by Inventia, classified under standard review priority.
Asset / Drug
Drug and asset intelligence for Inventia with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
SGLT2 Inhibitor
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.